A Bivalent Omicron-Containing Booster Vaccine against Covid-19Spyros Chalkias, Rituparna Das, Xing Chen et al.|New England Journal of Medicine|2022Cited by 649
Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trialSpyros Chalkias, Rituparna Das, Frank Eder et al.|Nature Medicine|2022Cited by 144
Original SARS-CoV-2 monovalent and Omicron BA.4/BA.5 bivalent COVID-19 mRNA vaccines: phase 2/3 trial interim resultsSpyros Chalkias, Rituparna Das, Jordan L. Whatley et al.|Nature Medicine|2023Cited by 77
Three-month antibody persistence of a bivalent Omicron-containing booster vaccine against COVID-19Spyros Chalkias, Rituparna Das, Lindsey R. Baden et al.|Nature Communications|2023Cited by 28